Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability
- PMID: 29074527
- PMCID: PMC5749189
- DOI: 10.1161/CIRCRESAHA.117.311947
Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability
Keywords: Editorials; bone marrow; heart failure; infusions, intravenous; mesenchymal stromal cells.
Comment on
- 
  
  Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).Circ Res. 2017 Oct 27;121(10):1192-1204. doi: 10.1161/CIRCRESAHA.117.310712. Epub 2017 Sep 26. Circ Res. 2017. PMID: 28974553 Free PMC article. Clinical Trial.
References
- 
    - Butler J, Epstein SE, Greene SJ, et al. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. Circ Res. 2017;120(2):332–340. - PubMed
 
- 
    - Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403. - PubMed
 
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        